Skip to content

A randomized controlled trial comparing the detection rate of real-time CEUS with conventional Doppler ultrasound guided transrectal prostate biopsy

A randomized controlled trial comparing the detection rate of real-time CEUS with conventional Doppler ultrasound guided transrectal prostate biopsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015770
Enrollment
Unknown
Registered
2018-04-19
Start date
2017-07-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Gold Standard:Doppler ultrasound guided prostate biopsy
ultrasound&#32
Contrast-guided&#32
Biopsy

Sponsors

The Third Affiliated Hospital of Southern Medical University, Department of Urology
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Blood prostate specific antigen 4-20ng/ml; 2) DRE or imaging abnormalities at any PSA level; 3) Aged more than 40 years old and less than 80 years old; 4) No other history of cancer; 5) No history of prostate surgery.

Exclusion criteria

Exclusion criteria: 1) There is a recent history of urinary tract infection or invasive urethral operation (urethral catheterization, cystoscopy, etc.); 2) Age <40 years old and abnormal imaging; 3) Imaging diagnosis is highly suspected of non-prostate cancer (eg, rhabdomyosarcoma, etc.).

Design outcomes

Primary

MeasureTime frame
Suspect Nodules Location and Quantity;Puncture pathological results;

Countries

China

Contacts

Public ContactCundong Liu

The Third Affiliated Hospital of Southern Medical University

403661379@qq.com+86 13825096552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026